Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy
The AACR Immuno-Oncology Conference (AACR IO) is being held in Los Angeles from 18 to 23 February 2026.
AACR IO encompasses the very best of basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies.
The inaugural AACR IO program in 2026 attracted over 600 scientists, translational researchers, clinical investigators, regulators, industry, investors, and lay press.
The unique format will include a mix of keynote lectures, major symposia, spotlight sessions, educational sessions, special sessions, and poster sessions with exhibits.
Location: JW Marriott Los Angeles L.A. LIVE, 900 W Olympic Blvd, Los Angeles, CA 90015, United States
Key Dates:
Advance Registration Deadline: Friday 9 January 2026.
Clinical Trial and Late-Breaking Abstract Submission Deadline: Tuesday 20 January 2026, 1 p.m. ET (opens Monday 5 January 2026)